Sep 10, 2020 — 5 min read
Recent studies have shown that Lunit’s AI solution is as accurate as average radiologists when it comes to identifying breast cancer and it could potentially have a role as independent reader in the future, to reduce radiologist workload and possibly to increase cancer detection.
A pair of studies conducted by Dr. Fredrik Strand from Karolinska Institutet and his research team have been recently published in JAMA Oncology and The Lancet Digital Health, well-known to be among the leading peer-reviewed journals in medicine, featuring performance results of Lunit INSIGHT MMG, a commercial AI solution for breast cancer detection from mammograms.
According to the study published in JAMA Oncology, the team conducted the first independent comparison of several commercialized AI. Three different AI algorithms were analyzed including Lunit’s solution (Lunit INSIGHT MMG) to identify breast cancer. They were evaluated in a large retrospective screening cohort.
Based on 8,805 cases, Lunit’s algorithm showed the best accuracy among others, showing around 15 percentage points higher sensitivity than the other two algorithms. It also surpassed the sensitivity of the first-reader radiologists, and achieved a synergistic sensitivity of 88.6% when combining first-readers and Lunit’s AI solution.
“The significant leap in performance comes from our proprietary algorithm, meticulously trained by an unprecedented quantity of data with accurate ground truth,” said Ki Hwan Kim, Chief Medical Officer of Lunit. “Our training dataset includes 72,000 biopsy-proven breast cancer cases, which is considerably more than other algorithms mentioned in the study.”
In line with the high performance, the possibility for AI to triage certain screening examinations was suggested in the study published in The Lancet Digital Health. It focused on how AI-based scoring can be used to reallocate radiologist time from clearly negative mammograms to cases requiring additional attention by radiologists, ultimately reducing their workload and improving cancer detection.
The study proved that for the majority of mammograms receiving a low abnormality score Lunit AI rarely missed any cancers when assessing the data alone, with no radiologists involved. If no radiologist resources were used for 60% of women with the lowest AI scores and were invested into doing MRI for the top 2% AI scores (that were negative after radiologist double reading of the mammograms), a net of 103 of 547 cancers would potentially have been detected up to 2 years earlier, corresponding to a detection rate of 68 cancers per 1000 supplemental screening examinations.
Fredrik Strand, a researcher at the Department of Oncology-Pathology at Karolinska Institutet and a radiologist at Karolinska University Hospital explained, “The studies show the potential of commercial AI algorithms as independent readers in screening mammography assessment on a clinically relevant level. The next step for us is to explore how well the Lunit AI algorithm works as an independent reader in a prospective clinical setting. In the future, I am convinced that AI image analysis will contribute to further improvements in overall survival for breast cancer patients.”
“As breast cancer is the second leading cause of death in women, early detection is the best defense in treating the disease,” says Brandon Suh, CEO of Lunit. “It is very meaningful for our algorithm’s high-performance level to be recognized in these well-designed studies based on a significant actual screening cohort data, and we hope to continuously provide the best solution for the right diagnosis of patients.”
Lunit wins Tumor Proliferation Assessment Challenge (TUPAC) 2016
Lunit to unveil data-driven imaging biomarker at RSNA 2016
Lunit to showcase AI-powered products at USCAP 2017
Lunit INSIGHT: The First-ever, Real-time Imaging AI Analytics on the Web
Cognitive biases and augmented intelligence in radiology
Lunit Returns to RSNA with Real-time Imaging Platform, Featuring Cloud-based A
Lunit Unveils “Lunit INSIGHT,” A New Real-time Imaging AI Platform on the Web at RSNA 2017
Lunit INSIGHT: Q&A with Brandon B. Suh, Chief Medical Officer at Lunit
Media Advisory: Lunit at RSNA 2018
Lunit Opens “Lunit INSIGHT for Mammography” for Public Access
Lunit Brings its Newest AI Solution for Mammography to RSNA 2018
Lunit Partners with Fujifilm and Salud Digna to Provide Medical AI Solution in Mexico
Lunit announces new members in its advisory board: Dr. Eliot Siegel, Dr. Linda Moy, and Dr. Khan Siddiqui
Lunit to Present Abstracts on AI-powered Precision Pathology at 2019 AACR Annual Meeting
Lunit to Showcase AI Solution for Breast Cancer at SBI 2019
Lunit to Present Findings on the Predictive Power of AI Biomarker for Lung Cancer Immunotherapy at ASCO 2019
Lunit Receives Korea MFDS Approval for its AI Solution for Breast Cancer, Lunit INSIGHT MMG
Lunit Gets Korea MFDS Approval for its AI Solution for Chest X-ray, Lunit INSIGHT CXR 2
Lunit at RSNA 2019
Lunit Announces its First CE Mark for AI-Powered Chest X-ray Analysis Software, Lunit INSIGHT CXR
Lunit AI software clinically installed in global sites—to be presented at RSNA 2019
AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall
Lunit Releases Its AI Online to Support Healthcare Professionals Manage COVID-19
Lunit to Present Findings on the Predictive Power of AI-based Analysis of Immune Phenotype at ASCO 2020
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
AI Solution for COVID-19, Developed by Medical AI Firm Lunit, Now Has Users in More Than 10 Countries
Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations
Emergent Connect Partners with Lunit to Provide Cloud Based AI Solutions
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
RSNA 2020--Lunit Collaborates with Global Giants in Presenting its AI Solution at Virtual Booths of GE Healthcare, FujiFilm, and Sectra
AI Proves Its Value in Assistance for Emergency Cases-- With Higher Accuracy and Timely Reporting Time of Chest Radiographs
Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry
AI Can Offer Fast and Reliable Examination to Triage COVID-19 Patients-- A Multicenter Retrospective Study Reveals
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
What do the medical journals say about AI-powered mammography?
Research Using Lunit Demo Website
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
What do the medical journals say about AI-powered chest x-ray interpretation?
Join our webinar with Dr. Fredrik Strand
From retrospective to prospective trials of AI in breast cancer screening
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
Case of the Month | Where Is Breast Cancer?
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI
Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit
Lunit Collaborates with Intel to Provide AI Solutions to CPU-Based Customers in Need of Effective X-ray Diagnosis